MedTrace Logo

A Study of Activity Leader to Forest Therapy Campaign in Different Environments Targets on the Participants Which Had Been Infected by SARS-COV-2

NCT06601920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2024-09-19

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the impact of self-guided forest healing activities and guided forest healing activities on the reduction of psychological stress inindividuals diagnosed with the new coronavirus. The main questions aim to answer are:

1. Effectiveness of Forest Healing Activities on Emotional Well-being: Researchers will compare the emotional improvement effects between self-guided and guided forest healing activities to determine their effectiveness.
2. Comparison of Healing Effects in Different Locations: Researchers will compare the effects of forest healing activities conducted in two similar environments, the Taipei Botanical Garden and the Chiayi Arboretum, to assess whether location influences outcomes despite similar altitude and latitude.

Participants who have been diagnosed with the new coronavirus will be recived two hours of guided forest healing activities or self-guided forest healing activities.

Conditions

  • Post COVID-19 Syndrome
  • Stress Disorders
  • Life Quality
  • Depression Anxiety Disorder

Interventions

BEHAVIORAL

Forest healing activities

The two-hour forest healing activity, led by horticultural therapists from the Taiwan Horticultural Therapy Association, includes activities such as leaf stacking on stones, listening to sounds with closed eyes, body stretching, blindfolded tree identification, \"my tree friend,\" earth mandala creation, tea tasting, and sharing of reflections.

Sponsors & Collaborators

  • Forestry Research Institute, Ministry of Agriculture, Taiwan

    collaborator UNKNOWN

  • Taipei City Hospital

    lead OTHER_GOV

Principal Investigators

  • Chung-Hua Hsu, MD., PhD. · Branch of Linsen Chinese Medicine and Kunming, Taipei City Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-27
Primary Completion
2024-01-17
Completion
2024-01-17

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06601920 on ClinicalTrials.gov